CD82 and breast cancer: Furthermore, another study identified and characterized a primary nuclear nonpolyadenylated antisense- (as-) lncRNA, named lncRNA SKAI1BC and representing as “suppressor of KAI1 in breast cancer”, could suppress KAI1/CD82 mRNA and protein expression in triple-negative breast cancer cell line MDA-MB-231 [44].